Dr Caitlin Filby is an experienced stem cell and molecular biologist and an emerging leader in the field of endometrial stem cells in endometriosis. She has developed novel stem cell tools that will increase our understanding of the pathogenesis of endometriosis and will lead to novel precision diagnostic and therapeutic options for endometriosis.
Dr Caitlin Filby obtained her PhD at Monash University and completed postdoctoral training at Walter and Eliza Hall Institute of Medical Research and Murdoch Childrens Research Institute. Dr Filby was recently recruited to the Hudson Institute of Medical Research by Professor Caroline Gargett to investigate the pathogenesis of endometriosis. Her long-term career goal is to be an internationally-recognized endometriosis researcher who translates scientific discoveries into improved patient outcomes. She is passionate about endometriosis research and equal opportunities for women.
She is currently working on a US Dept. of Defence-funded collaborative grant on endometriosis and has received her own funding from EndoFound.